DLC-1 (Loss of deleted in liver cancer-1) induced mitochondrial apoptosis, and inhibited EMT in nasopharyngeal carcinoma by targeting the EGFR/Akt/NF-κB pathway [35]. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.